Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1207 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Veverimer for metabolic acidosis associated with chronic kidney disease	TRC101 (Veverimer)	Metabolic acidosis	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders , Nephrology	2020	View \| Download
VF-001 (VitroGro ECM) for venous leg ulcer	VF-001 (VitroGro ECM)	Venous leg ulcers	Cardiovascular System , Dermatology	2017	View \| Download
Viaskin Peanut – peanut allergy immunotherapy (DBV 712; EPIT Peanut) for paediatric patients aged 4-11	DBV-712 (Viaskin peanut)	Peanut allergy	Immunology	2017	View \| Download
Vibegron for treating overactive bladder	Vibegron (MK-418; Gemtesa; Beova)	Overactive bladder	Urology	2023	View \| Download
Vibostolimab-pembrolizumab for previously untreated PD-L1-positive metastatic non-small cell lung cancer	Pembrolizumab-vibostolimab (MK-7684; MK7684A; Vibostolimab)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Vimseltinib for treating Tenosynovial Giant Cell Tumour	Vimseltinib (DCC-3014)	Tenosynovial giant cell tumour (TGCT)	Oncology	2024	View \| Download
Voclosporin for lupus nephritis	Voclosporin (ISA247)	Lupus nephritis	Immunology , Nephrology	2021	View \| Download
Volixibat for non-alcoholic steatohepatitis (NASH)	Volixibat (SHP626; LUM-002)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2017	View \| Download
Vonicog alfa for Prophylaxis of Haemorrhage in Von Willebrand disease	Vonicog alfa (recombinant von Willebrand factor)	von Willebrand disease	Genetic Disorders , Haematology	2023	View \| Download
Vorasidenib for treating residual or recurrent grade 2 glioma	Vorasidenib	Glioma	Neurological Cancer	2023	View \| Download